Paladin and P&G sign co-promotion agreement for oral contraceptive

Under this co-promotion agreement, Paladin will maintain regulatory and supply responsibilities for Seasonale and will continue to support Seasonale using its national specialty sales force. P&G Pharmaceuticals Canada will provide marketing, promotion, trade distribution and will deploy a national sales force in support of Seasonale.

With Seasonale, Canadian women have an oral contraceptive option that will allow them to have just four periods per year.

Jonathan Goodman, president and CEO of Paladin Labs, said: “P&G is the world’s largest consumer product company and offers the pharmaceutical expertise and proven alliance management capabilities that made it our preferred partner for helping to grow Seasonale in Canada.”